CoChat

Tropisms of AAV for Subretinal Delivery to the Neonatal Mouse Retina and Its Application for In Vivo Rescue of Developmental Photoreceptor Disorders

Open access

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Adeno-associated virus (AAV) is well established as a vehicle for in vivo gene transfer into the mammalian retina. This virus is promising not only for gene therapy of retinal diseases, but also for in vivo functional analysis of retinal genes. Previous reports have shown that AAV can infect various cell types in the developing mouse retina. However, AAV tropism in the developing retina has not yet been examined in detail. METHODOLOGY/PRINCIPAL FINDINGS: We subretinally delivered seven AAV serotypes (AAV2/1, 2/2, 2/5, 2/8, 2/9, 2/10, and 2/11) of AAV-CAG-mCherry into P0 mouse retinas, and quantitatively evaluated the tropisms of each serotype by its infecting degree in retinal cells. After subretinal injection of AAV into postnatal day 0 (P0) mouse retinas, various retinal cell types were efficiently transduced with different AAVs. Photoreceptor cells were efficiently transduced with AAV2/5. Retinal cells, except for bipolar and Müller glial cells, were efficiently transduced with AAV2/9. Horizontal and/or ganglion cells were efficiently transduced with AAV2/1, AAV2/2, AAV2/8, AAV2/9 and AAV2/10. To confirm the usefulness of AAV-mediated gene transfer into the P0 mouse retina, we performed AAV-mediated rescue of the Cone-rod homeobox gene knockout (Crx KO) mouse, which exhibits an outer segment formation defect, flat electroretinogram (ERG) responses, and photoreceptor degeneration. We injected an AAV expressing Crx under the control of the Crx 2kb promoter into the neonatal Crx KO retina. We showed that AAV mediated-Crx expression significantly decreased the abnormalities of the Crx KO retina. CONCLUSION/SIGNIFICANCE: In the current study, we report suitable AAV tropisms for delivery into the developing mouse retina. Using AAV2/5 in photoreceptor cells, we demonstrated the possibility of gene replacement for the developmental disorder and subsequent degeneration of retinal photoreceptors caused by the absence of Crx.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0054146

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Tropisms of seven AAV serotypes in the P0 mouse retina. (A) Schematic diagram of the AAV-CAG-mCherry construct. This AAV drives ubiquitous expression of mCherry under the control of the CAG promoter. (B) Fluorescence images of the distribution of mCherry expression in whole retinas (photoreceptor-side-up) two weeks after subretinal injection with PBS or one of each of the seven serotypes of AAV-CAG-mCherry. (C–I) Fluorescence images of mCherry expression two weeks after subretinal injection into the P0 mouse retina with AAV2/1- (C), AAV2/2- (D), AAV2/5- (E), AAV2/8- (F), AAV2/9 (G), AAV2/10- (H), and AAV2/11- (I), CAG-mCherry. Scale bar represents 1 mm (B) and 50 µm (C–I). ITR: inverted terminal repeat, RPE: retinal pigment epithelium, ONL: outer nuclear layer, INL: inner nuclear layer, GCL: ganglion cell layer.
Figure 1 Tropisms of seven AAV serotypes in the P0 mouse retina. (A) Schematic diagram of the AAV-CAG-mCherry construct. This AAV drives ubiquitous expression of mCherry under the control of the CAG promoter. (B) Fluorescence images of the distribution of mCherry expression in whole retinas (photoreceptor-side-up) two weeks after subretinal injection with PBS or one of each of the seven serotypes of AAV-CAG-mCherry. (C–I) Fluorescence images of mCherry expression two weeks after subretinal injection into the P0 mouse retina with AAV2/1- (C), AAV2/2- (D), AAV2/5- (E), AAV2/8- (F), AAV2/9 (G), AAV2/10- (H), and AAV2/11- (I), CAG-mCherry. Scale bar represents 1 mm (B) and 50 µm (C–I). ITR: inverted terminal repeat, RPE: retinal pigment epithelium, ONL: outer nuclear layer, INL: inner nuclear layer, GCL: ganglion cell layer.CC BY · PubMed Central
Figure 2 Infection efficiencies of seven AAV serotypes in each retinal cell type. (A) Schematic diagram of quantification method of infection efficiency. Two weeks after subretinal injection, the retinas were immunostained with antibodies of retinal cell type-specific makers (Rod: RHODOPSIN (RHO), Cone: S-OPSIN, Horizontal: CALB1, Bipolar: CHX10, Amacrine: PAX6, Ganglion: BRN3B, Müller: S100β). According to retinal cell types, the numbers of marker-positive and marker/mCherry double-positive cells were counted for calculation of infection efficiency (n = 3 from three different mice). Cells were counted in the central area of the retina for calculating the infection efficiencies of cone photoreceptor, bipolar, and Müller glial cells, and in the central, middle and peripheral areas of the retina for calculating the infection efficiencies of rod photoreceptor and amacrine cells. Infection efficiency was calculated using the formula indicated in Figure 2A. (B–H) Infection efficiencies of AAV2/1- (B), AAV2/2- (C), AAV2/5- (D), AAV2/8- (E), AAV2/9- (F), AAV2/10- (G), and AAV2/11- (H), CAG-mCherry. Error bar represents the SD from the means of three retinas. ONH: optic nerve head.
Figure 2 Infection efficiencies of seven AAV serotypes in each retinal cell type. (A) Schematic diagram of quantification method of infection efficiency. Two weeks after subretinal injection, the retinas were immunostained with antibodies of retinal cell type-specific makers (Rod: RHODOPSIN (RHO), Cone: S-OPSIN, Horizontal: CALB1, Bipolar: CHX10, Amacrine: PAX6, Ganglion: BRN3B, Müller: S100β). According to retinal cell types, the numbers of marker-positive and marker/mCherry double-positive cells were counted for calculation of infection efficiency (n = 3 from three different mice). Cells were counted in the central area of the retina for calculating the infection efficiencies of cone photoreceptor, bipolar, and Müller glial cells, and in the central, middle and peripheral areas of the retina for calculating the infection efficiencies of rod photoreceptor and amacrine cells. Infection efficiency was calculated using the formula indicated in Figure 2A. (B–H) Infection efficiencies of AAV2/1- (B), AAV2/2- (C), AAV2/5- (D), AAV2/8- (E), AAV2/9- (F), AAV2/10- (G), and AAV2/11- (H), CAG-mCherry. Error bar represents the SD from the means of three retinas. ONH: optic nerve head.CC BY · PubMed Central
Figure 3 Gene expression analysis of the Crx KO retina treated with AAV-Crx. (A) Schematic diagram of the AAV2/5-Crx2kb-Flag-Crx construct. (B) Expression analysis of Crx by RT-qPCR using RNA isolated from control and AAV-treated Crx KO retinas (Control Crx KO retinas: n = 3 from three different mice and AAV-treated Crx KO retinas: n = 4 from four different mice). (C) Western blot analysis of FLAG-CRX using control and AAV-treated Crx KO retinas from three different mice respectively. An anti-FLAG antibody was used to detect FLAG-CRX. ACTB (β-actin) was used as a loading control. (D–F) Immunostaining of the Crx KO retinas treated with AAV-Crx or PBS using an anti-FLAG antibody. The distribution of FLAG-CRX expression in control and AAV-Crx treated Crx KO retinas (E, F). Enlarged images in white boxes (a-c and d-f) in Figure 3E and F, respectively. Scale bar represents 50 µm (D) and 1 mm (E, F). (G–Q) Expression analyses of eleven genes related to human retinal diseases three weeks after treatment (Control Crx KO retinas: n = 3 from three different mice and AAV-treated Crx KO retinas: n = 4 from four different mice). Rhodopsin (G), Gnat1 (H), S-opsin (I), M-opsin (J), Pde6g (K), Slc24a1 (L), Rdh12 (M), Rpgrip1 (N), Nrl (O), Cabp4 (P), and Fscn2 (Q). Control retinas were injected with PBS (Vehicle). Rpl4 was used for normalization. Primers for qPCR were listed in Table S1. Error bar represents the SD from the means of three control retinas and four treated retinas. ** p<0.01, * p<0.05. ITR: inverted terminal repeat, RPE: retinal pigment epithelium, ONL: outer nuclear layer, INL: inner nuclear layer, GCL: ganglion cell layer.
Figure 3 Gene expression analysis of the Crx KO retina treated with AAV-Crx. (A) Schematic diagram of the AAV2/5-Crx2kb-Flag-Crx construct. (B) Expression analysis of Crx by RT-qPCR using RNA isolated from control and AAV-treated Crx KO retinas (Control Crx KO retinas: n = 3 from three different mice and AAV-treated Crx KO retinas: n = 4 from four different mice). (C) Western blot analysis of FLAG-CRX using control and AAV-treated Crx KO retinas from three different mice respectively. An anti-FLAG antibody was used to detect FLAG-CRX. ACTB (β-actin) was used as a loading control. (D–F) Immunostaining of the Crx KO retinas treated with AAV-Crx or PBS using an anti-FLAG antibody. The distribution of FLAG-CRX expression in control and AAV-Crx treated Crx KO retinas (E, F). Enlarged images in white boxes (a-c and d-f) in Figure 3E and F, respectively. Scale bar represents 50 µm (D) and 1 mm (E, F). (G–Q) Expression analyses of eleven genes related to human retinal diseases three weeks after treatment (Control Crx KO retinas: n = 3 from three different mice and AAV-treated Crx KO retinas: n = 4 from four different mice). Rhodopsin (G), Gnat1 (H), S-opsin (I), M-opsin (J), Pde6g (K), Slc24a1 (L), Rdh12 (M), Rpgrip1 (N), Nrl (O), Cabp4 (P), and Fscn2 (Q). Control retinas were injected with PBS (Vehicle). Rpl4 was used for normalization. Primers for qPCR were listed in Table S1. Error bar represents the SD from the means of three control retinas and four treated retinas. ** p<0.01, * p<0.05. ITR: inverted terminal repeat, RPE: retinal pigment epithelium, ONL: outer nuclear layer, INL: inner nuclear layer, GCL: ganglion cell layer.CC BY · PubMed Central
Figure 4 Histological analyses of the Crx KO retina transduced with AAV-Crx. (A–P) Immunostaining of the Crx KO retinas three weeks after AAV-Crx treatment with outer segment makers of rod photoreceptor (A–H) and cone photoreceptor cells (I–P). Scale bars represent 20 µm (A–P). (Q–S) Transmission electron microscopy analysis of retinas fifteen weeks after AAV-Crx treatment. (Q and R) In control retinas, no photoreceptor cell was observed (Q). In AAV-Crx-treated retinas, some outer segment structures were observed (R). (S) An enlarged image of outer segments in AAV-Crx-treated retinas. Arrowheads indicate outer segment containing disk lamina. Scale bars represent 7.5 µm (Q and R) and 5 µm (S). RPE: retinal pigment epithelium, ONL: outer nuclear layer, OPL: outer plexiform layer, INL: inner nuclear layer, GCL: ganglion cell layer. OS: outer segment, IS: inner segment.
Figure 4 Histological analyses of the Crx KO retina transduced with AAV-Crx. (A–P) Immunostaining of the Crx KO retinas three weeks after AAV-Crx treatment with outer segment makers of rod photoreceptor (A–H) and cone photoreceptor cells (I–P). Scale bars represent 20 µm (A–P). (Q–S) Transmission electron microscopy analysis of retinas fifteen weeks after AAV-Crx treatment. (Q and R) In control retinas, no photoreceptor cell was observed (Q). In AAV-Crx-treated retinas, some outer segment structures were observed (R). (S) An enlarged image of outer segments in AAV-Crx-treated retinas. Arrowheads indicate outer segment containing disk lamina. Scale bars represent 7.5 µm (Q and R) and 5 µm (S). RPE: retinal pigment epithelium, ONL: outer nuclear layer, OPL: outer plexiform layer, INL: inner nuclear layer, GCL: ganglion cell layer. OS: outer segment, IS: inner segment.CC BY · PubMed Central
Figure 5 Restoration of function and morphology in the Crx KO retina treated with AAV-Crx. (A) Representative ERGs recorded at six and fifteen weeks after AAV-Crx treatment. ERG responses averaged from one hundred 1.0 log cd-s/m2 stimuli. The mice used for ERG recordings were independently prepared between the two time points. At both six and fifteen weeks after AAV treatment, all three of the control eyes from different mice showed no ERG response, while two of the three treated eyes from different mice showed significant responses. (B) Immunostaining of FLAG-CRX in the retinas at fifteen weeks after AAV-Crx treatment. (C and D) Immunostaining of active-caspase-3 and FLAG-CRX in Crx KO retinas three weeks after AAV-Crx treatment (C). The number of active-caspase-3-positive cells (D, Control retinas: n = 3 from three different mice and AAV-treated Crx KO retinas: n = 4 from four different mice). Arrowheads indicate active-caspase-3-positive cells. Scale bar represents 50 µm. Error bar represents the SD from the means of three control retinas and four treated retinas. * p<0.05. RPE: retinal pigment epithelium, ONL: outer nuclear layer, INL: inner nuclear layer, GCL: ganglion cell layer.
Figure 5 Restoration of function and morphology in the Crx KO retina treated with AAV-Crx. (A) Representative ERGs recorded at six and fifteen weeks after AAV-Crx treatment. ERG responses averaged from one hundred 1.0 log cd-s/m2 stimuli. The mice used for ERG recordings were independently prepared between the two time points. At both six and fifteen weeks after AAV treatment, all three of the control eyes from different mice showed no ERG response, while two of the three treated eyes from different mice showed significant responses. (B) Immunostaining of FLAG-CRX in the retinas at fifteen weeks after AAV-Crx treatment. (C and D) Immunostaining of active-caspase-3 and FLAG-CRX in Crx KO retinas three weeks after AAV-Crx treatment (C). The number of active-caspase-3-positive cells (D, Control retinas: n = 3 from three different mice and AAV-treated Crx KO retinas: n = 4 from four different mice). Arrowheads indicate active-caspase-3-positive cells. Scale bar represents 50 µm. Error bar represents the SD from the means of three control retinas and four treated retinas. * p<0.05. RPE: retinal pigment epithelium, ONL: outer nuclear layer, INL: inner nuclear layer, GCL: ganglion cell layer.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 59

Metadata

Authors
Watanabe, S., Sanuki, R., Ueno, S., Koyasu, T., Hasegawa, T., & Furukawa, T.
Affiliations
  • Kyoto University (JP)
  • Japan Science and Technology Agency (JP)
  • Nagoya University (JP)
  • Research Center for Ultra-High Voltage Electron Microscopy, The University of Osaka (JP)
Corresponding author
Furukawa, Takahisa
Venue
PLoS ONE
Published
2013-01-15
Volume
8
Issue
1
Pages
e54146
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2094918722
Cited by
59
References
29
Citations by year
2026: 4 · 2025: 6 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 6 · 2020: 6 · 2019: 3 · 2018: 4 · 2017: 4 · 2016: 4 · 2015: 7 · 2014: 3 · 2013: 2
FWCI
2.39
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Kyoto University Research Information Repository (Kyoto University) (submittedVersion)
Funders
  • Naito Foundation
  • Takeda Science Foundation
  • Novartis Foundation
  • Uehara Memorial Foundation (CREST)
  • Daiichi-Sankyo
  • Kato Memorial Bioscience Foundation
  • Senri Life Science Foundation
  • Research Foundation for Opto-Science and Technology
  • Japan Society for the Promotion of Science (20390087, 24700360, 13J02346, 23390074)
  • Japan Science and Technology Agency (CREST)
  • Core Research for Evolutional Science and Technology
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
adeno-associated virus, AAV serotypes, AAV tropism, subretinal gene delivery, retinal development, photoreceptors, AAV2/5, AAV2/9, CRX, photoreceptor degeneration, retinal gene therapy, Müller cells
MeSH terms
Dependovirus, Animals, Electroretinography, Genetic Vectors, Photoreceptor Cells, Retina, Retinal Degeneration, Transduction, Genetic, Trans-Activators, Gene Expression, Gene Transfer Techniques, Homeodomain Proteins, Mice, Gene Knockout Techniques, Viral Tropism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tropisms of AAV for Subretinal Delivery to the Neonatal Mouse Retina and Its Application for In Vivo Rescue of Developmental Photoreceptor Disorders. https://app.cochat.ai/papers/10.1371/journal.pone.0054146
The paper
Watanabe, S., Sanuki, R., Ueno, S., Koyasu, T., Hasegawa, T., & Furukawa, T. (2013). Tropisms of AAV for Subretinal Delivery to the Neonatal Mouse Retina and Its Application for In Vivo Rescue of Developmental Photoreceptor Disorders. PLoS ONE. https://doi.org/10.1371/journal.pone.0054146

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.